Receptors
Showing 1 - 25 of 6,124
Preeclampsia Postpartum Trial in Iowa City (Compound 21)
Recruiting
- Preeclampsia Postpartum
- Compound 21
-
Iowa City, IowaUniversity of Iowa
Jul 7, 2023
Somatostatin Receptors and GH Receptor Expression on Bone of
Completed
- Evaluation of the Expression of Somatostatin Receptors and GH Receptor on Bone of Acromegalic Patients
- Trans-sphenoidal surgery
-
Roma, ItalyFondazione Policlinnico Gemelli IRCCS
Apr 6, 2023
Atypical Antipsychotics inGeriatric Population: What is Role of
Recruiting
- Neutropenia
-
Strasbourg, FranceService de Pharmacie - Stérilisation - CHU de Strasbourg - Franc
Oct 27, 2023
Vasoconstriction, Vasodilation Trial in Edmonton (Phenylephrine Hydrochloride, Isoproterenol Hydrochloride, Norepinephrine
Not yet recruiting
- Vasoconstriction
- Vasodilation
- Phenylephrine Hydrochloride
- +4 more
-
Edmonton, Alberta, CanadaUniversity of Alberta
Aug 21, 2023
Muscle, Fat and Tissue Receptors
Active, not recruiting
- Gender Incongruence
- Transgenderism
- testosterone cypionate
- Estradiol Valerate
-
Saint Louis, MissouriSaint Louis Univeristy
Jan 13, 2023
Peripheral Neuropathies Trial in San Antonio (Cryotherapy)
Active, not recruiting
- Peripheral Neuropathies
- Cryotherapy
-
San Antonio, TexasUT Health Cancer Center
Jan 21, 2023
LILRA3 in Ankylosing Spondylitis and Axial Psoriatic Patients
Not yet recruiting
- Autoimmune Diseases
- Leukocyte Immunoglobulin-like receptors A3
- (no location specified)
Jun 14, 2023
Prostate Cancer, Breast Cancer Trial in Tomsk (Intravenous injection of [99mTc]Tc-DB8)
Recruiting
- Prostate Cancer
- Breast Cancer
- Intravenous injection of [99mTc]Tc-DB8
-
Tomsk, Russian FederationTomskNRMC
Jul 4, 2023
Gastrointestinal Surgery Trial in XIan (sufentanil + nalbuphine, Sufentanil, hydromorphone + nalbuphine)
Completed
- Gastrointestinal Surgery
- sufentanil + nalbuphine
- +2 more
-
XIan, Shanxi, ChinaYANLI
Oct 11, 2022
Obesity Trial in Orlando (Oral Glucose Tolerance Test (OGTT), Assessment of dietary compliance, Stool sampling)
Completed
- Obesity
- Oral Glucose Tolerance Test (OGTT)
- +5 more
-
Orlando, FloridaTranslational Research Institute for Metabolism and Diabetes
Feb 1, 2023
Opioid Use Disorder Trial (CVL-354, [11C]-LY2795050, [11C]-carfentanil)
Not yet recruiting
- Opioid Use Disorder
- CVL-354
- +2 more
-
New Haven, ConnecticutNew Haven, Connecticut
Jan 18, 2023
Solid Tumor, Adult Trial in Tomsk (Diagnostic Test: whole body study and SPECT with [99mTc]Tc(CO)3-(HE)3-Ec1)
Enrolling by invitation
- Solid Tumor, Adult
- Diagnostic Test: whole body study and SPECT with [99mTc]Tc(CO)3-(HE)3-Ec1
-
Tomsk, Russian FederationTomskNRMC
Jan 23, 2023
Complement C5a Receptors in Hidradenitis Suppurativa
Recruiting
- Hidradenitis Suppurativa
-
Redwood City, CaliforniaStanford University
Jun 27, 2022
Hormonal Associations in Male Patients With Psoriasis Vulgaris
Not yet recruiting
- Psoriasis Vulgaris
- Morning blood sample and skin punch biopsy of 4 mm diameter.
- (no location specified)
Feb 3, 2023
Functional Relevance of Dopamine Receptors in Healthy Controls
Recruiting
- Schizoaffective Disorder
- Schizophrenia
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
LANDscape MApping of Epitopes and T Cell Receptors for Selected
Recruiting
- Solid Tumor
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 21, 2022
Venous Ulcer, Sickle Cell Ulcer, Diabetic Ulcer Trial in Paris (Saliva sampling, Blood sampling, Interviews)
Not yet recruiting
- Venous Ulcer
- +3 more
- Saliva sampling
- +3 more
-
Paris, Ile De France, FranceDermatology unit - Cochin Hospital - APHP
Sep 8, 2023
HER2 Negative Breast Cancer Not Immediately Operated Trial (Ribociclib Oral Tablet)
Not yet recruiting
- HER2 Negative Breast Cancer Not Immediately Operated
- Ribociclib Oral Tablet
- (no location specified)
Dec 16, 2022
Parkinson Disease Trial in Ann Arbor (Flumazenil, Placebo)
Completed
- Parkinson Disease
- Flumazenil
- Placebo
-
Ann Arbor, MichiganUniversity of Michigan Functional Neuroimaging, Cognitive and Mo
Jun 4, 2022
Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals
Not yet recruiting
- Preterm Labor
- (no location specified)
May 9, 2023
COPD Trial in Hannover (Bronchoscopy)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Bronchoscopy
-
Hannover, Niedersachsen, GermanyFraunhofer ITEM
Mar 21, 2022
Neuroblastoma Trial in Lille, Lyon, Toulouse (PRRT with 177Lu-DOTATATE)
Not yet recruiting
- Neuroblastoma
- PRRT with 177Lu-DOTATATE
-
Lille, France
- +2 more
Nov 8, 2022
Prostate Cancer, Breast Cancer Female Trial in Tomsk (whole body study and SPECT with 99mTc-RM26)
Enrolling by invitation
- Prostate Cancer
- Breast Cancer Female
- whole body study and SPECT with 99mTc-RM26
-
Tomsk, Russian FederationTomskNRMC
Jul 4, 2022
Schizophrenia Trial in Boston (CVL-231)
Recruiting
- Schizophrenia
-
Boston, MassachusettsMassachusetts General Hospital Translational and Clinical Resear
Jul 6, 2022